Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2009 - 2026)

Zimmer Biomet Holdings' (ZBH) quarterly Total Non-Current Liabilities came in at $9.4 billion in Q1 2026, down 2.42% year-on-year from $9.6 billion in Q1 2025, and down 3.59% quarter-over-quarter from $9.8 billion in Q4 2025.

Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Zimmer Biomet Holdings' Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $9.4 billion for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 2.42% year-over-year to $9.4 billion in Q1 2026; TTM through Mar 2026 was $9.4 billion, a 2.42% decrease from a year earlier, with the FY2025 full-year figure at $9.8 billion, up 12.07% from the prior year.
  • Total Non-Current Liabilities declined to $9.4 billion in Q1 2026 per ZBH's latest filing, from $9.8 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $9.9 billion in Q3 2025 and bottomed at $7.6 billion in Q2 2024.
  • The 5-year median for Total Non-Current Liabilities is $8.6 billion (2024), against an average of $8.8 billion.
  • Across the five-year window, Total Non-Current Liabilities slipped 20.99% in 2022 and advanced 24.94% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $8.4 billion in 2022, then declined by 3.85% to $8.1 billion in 2023, then grew by 7.74% to $8.7 billion in 2024, then grew by 12.07% to $9.8 billion in 2025, then declined by 3.59% to $9.4 billion in 2026.
  • Per Business Quant, the three latest ZBH Total Non-Current Liabilities figures stand at $9.4 billion (Q1 2026), $9.8 billion (Q4 2025), and $9.9 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Zimmer Biomet Holdings 17.48 Bn 17.07 Bn 1.51 Bn 9.41 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.41 Bn
Dec 31, 2025 9.76 Bn
Sep 30, 2025 9.92 Bn
Jun 30, 2025 9.45 Bn
Mar 31, 2025 9.64 Bn
Dec 31, 2024 8.71 Bn
Sep 30, 2024 8.31 Bn
Jun 30, 2024 7.57 Bn
Mar 31, 2024 8.57 Bn
Dec 31, 2023 8.08 Bn
Sep 30, 2023 8.30 Bn
Jun 30, 2023 8.27 Bn
Mar 31, 2023 8.45 Bn
Dec 31, 2022 8.41 Bn
Sep 30, 2022 8.47 Bn
Jun 30, 2022 8.74 Bn
Mar 31, 2022 9.04 Bn
Dec 31, 2021 10.24 Bn
Sep 30, 2021 10.70 Bn
Jun 30, 2021 11.06 Bn